Literature DB >> 20842452

Golgi phosphoprotein 2 (GOLPH2/GP73/GOLM1) interacts with secretory clusterin.

Yan Zhou1, Leike Li, Longbo Hu, Tao Peng.   

Abstract

Golgi phosphoprotein 2 (GOLPH2/GP73/GOLM1), a type-II Golgi transmembrane protein of unknown function, is up-regulated in many cancers. Its Golgi luminal domain is potentially the major functional domain. The goal of this study is to identify the proteins interacting with GOLPH2. Using secretory GOLPH2 (sGOLPH2, amino acid residues 55-401) as bait, secretory clusterin (sCLU) was identified as one interacting candidate by yeast two-hybrid screening, and the coiled-coil domain of GOLPH2 was found to be sufficient for interaction with sCLU. The interaction between GOLPH2 and sCLU was confirmed intracellularly and extracellularly. The intracellular co-localization of GOLPH2 and sCLU in Golgi was also shown. These results can help in understanding the biological and pathological significance of GOLPH2.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20842452     DOI: 10.1007/s11033-010-0251-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  18 in total

Review 1.  Clusterin.

Authors:  Steve E Jones; Catherine Jomary
Journal:  Int J Biochem Cell Biol       Date:  2002-05       Impact factor: 5.085

Review 2.  Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer.

Authors:  B Shannan; M Seifert; K Leskov; J Willis; D Boothman; W Tilgen; J Reichrath
Journal:  Cell Death Differ       Date:  2006-01       Impact factor: 15.828

3.  Serum clusterin and vitronectin in alcoholic cirrhosis.

Authors:  K Høgåsen; C Homann; T E Mollnes; N Graudal; A K Høgåsen; P Hasselqvist; A C Thomsen; P Garred
Journal:  Liver       Date:  1996-04

4.  Clusterin plays an important role in hepatocellular carcinoma metastasis.

Authors:  S H Lau; J S T Sham; D Xie; C-H Tzang; D Tang; N Ma; L Hu; Y Wang; J-M Wen; G Xiao; W-M Zhang; G K K Lau; M Yang; X-Y Guan
Journal:  Oncogene       Date:  2006-02-23       Impact factor: 9.867

5.  Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease.

Authors:  Raleigh D Kladney; Xiaoyen Cui; Gary A Bulla; Elizabeth M Brunt; Claus J Fimmel
Journal:  Hepatology       Date:  2002-06       Impact factor: 17.425

6.  Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas.

Authors:  Marc-Oliver Riener; Frank Stenner; Heike Liewen; Christopher Soll; Stefan Breitenstein; Bernhard Cornelius Pestalozzi; Panagiotis Samaras; Nicole Probst-Hensch; Claus Hellerbrand; Beat Müllhaupt; Pierre-Alain Clavien; Marcus Bahra; Peter Neuhaus; Peter Wild; Florian Fritzsche; Holger Moch; Wolfram Jochum; Glen Kristiansen
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

7.  GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population.

Authors:  Jin-song Hu; De-wu Wu; Shuo Liang; Xiong-yin Miao
Journal:  Med Oncol       Date:  2009-04-28       Impact factor: 3.064

8.  Quantitative analysis of elevated serum Golgi protein-73 expression in patients with liver diseases.

Authors:  Yanli Gu; Wenli Chen; Yu Zhao; Liyun Chen; Tao Peng
Journal:  Ann Clin Biochem       Date:  2008-11-13       Impact factor: 2.057

9.  GP73, a novel Golgi-localized protein upregulated by viral infection.

Authors:  R D Kladney; G A Bulla; L Guo; A L Mason; A E Tollefson; D J Simon; Z Koutoubi; C J Fimmel
Journal:  Gene       Date:  2000-05-16       Impact factor: 3.688

10.  GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics.

Authors:  G Kristiansen; F R Fritzsche; K Wassermann; C Jäger; A Tölls; M Lein; C Stephan; K Jung; C Pilarsky; M Dietel; H Moch
Journal:  Br J Cancer       Date:  2008-09-16       Impact factor: 7.640

View more
  20 in total

1.  Interleukin-6 and oncostatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73.

Authors:  Hongyan Liang; Timothy M Block; Mengjun Wang; Bradley Nefsky; Ronald Long; Julie Hafner; Anand S Mehta; Jorge Marrero; Robert Gish; Pamela A Norton
Journal:  Cancer Biomark       Date:  2012       Impact factor: 4.388

2.  Analysis of GP73 in patients with HCC as a function of anti-cancer treatment.

Authors:  Hie-Won Hann; Mengjun Wang; Julie Hafner; Ronald E Long; Su Hee Kim; Meejin Ahn; Susan Park; Mary Ann Comunale; Timothy M Block; Anand Mehta
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

3.  The Golgi localization of GOLPH2 (GP73/GOLM1) is determined by the transmembrane and cytoplamic sequences.

Authors:  Longbo Hu; Leike Li; Hongbin Xie; Yanli Gu; Tao Peng
Journal:  PLoS One       Date:  2011-11-29       Impact factor: 3.240

4.  Xenopus as a model system for the study of GOLPH2/GP73 function: Xenopus GOLPH2 is required for pronephros development.

Authors:  Leike Li; Luan Wen; Yu Gong; Guoqiang Mei; Jinsong Liu; Yonglong Chen; Tao Peng
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

5.  GP73 is down-regulated in gastric cancer and associated with tumor differentiation.

Authors:  Le-Gao Chen; Hui-Ju Wang; Hai-bo Yao; Tian-Pei Guan; Fang Wu; Xu-Jun He; Ying-Yu Ma; Hou-Quan Tao; Zai-Yuan Ye
Journal:  World J Surg Oncol       Date:  2013-06-07       Impact factor: 2.754

6.  GP73 is upregulated by hepatitis C virus (HCV) infection and enhances HCV secretion.

Authors:  Longbo Hu; Wenxia Yao; Fang Wang; Xia Rong; Tao Peng
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

7.  CXCL10 decreases GP73 expression in hepatoma cells at the early stage of hepatitis C virus (HCV) infection.

Authors:  Yuan Liu; Ziying Zou; Bing Zhu; Zonghai Hu; Ping Zeng
Journal:  Int J Mol Sci       Date:  2013-12-13       Impact factor: 5.923

8.  Golgi phosphoprotein 2 (GOLPH2) is a novel bile acid-responsive modulator of oesophageal cell migration and invasion.

Authors:  Anne-Marie Byrne; Spiros Bekiaris; Gina Duggan; David Prichard; Murat Kirca; Stephen Finn; John V Reynolds; Dermot Kelleher; Aideen Long
Journal:  Br J Cancer       Date:  2015-10-13       Impact factor: 7.640

9.  Golgi phosphoprotein 2 in physiology and in diseases.

Authors:  Ha-Jeong Kim; Dandan Lv; Yan Zhang; Tao Peng; Xiaojing Ma
Journal:  Cell Biosci       Date:  2012-09-10       Impact factor: 7.133

10.  High GP73 Expression Correlates with Poor Response to Neoadjuvant Chemotherapy and Survival in Gastric Cancer: A Tissue Microarray Study.

Authors:  Jian Guo Shen; Jun Shen; Rong Yue Teng; Lin Bo Wang; Wen He Zhao; Qin Chuan Wang
Journal:  Pathol Oncol Res       Date:  2021-03-30       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.